1. Home
  2. ARVN vs EBF Comparison

ARVN vs EBF Comparison

Compare ARVN & EBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$10.04

Market Cap

658.2M

Sector

Health Care

ML Signal

HOLD

Logo Ennis Inc.

EBF

Ennis Inc.

HOLD

Current Price

$20.68

Market Cap

533.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARVN
EBF
Founded
2015
1909
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
658.2M
533.9M
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
ARVN
EBF
Price
$10.04
$20.68
Analyst Decision
Buy
Analyst Count
19
0
Target Price
$15.05
N/A
AVG Volume (30 Days)
640.4K
169.4K
Earning Date
05-04-2026
04-20-2026
Dividend Yield
N/A
4.85%
EPS Growth
58.84
N/A
EPS
N/A
1.31
Revenue
$262,600,000.00
N/A
Revenue This Year
N/A
$2.96
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$15.49
Revenue Growth
N/A
N/A
52 Week Low
$5.90
$16.30
52 Week High
$14.22
$22.36

Technical Indicators

Market Signals
Indicator
ARVN
EBF
Relative Strength Index (RSI) 40.04 47.27
Support Level $9.96 $19.96
Resistance Level $10.18 $21.52
Average True Range (ATR) 0.55 0.59
MACD 0.03 -0.02
Stochastic Oscillator 20.36 64.67

Price Performance

Historical Comparison
ARVN
EBF

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

About EBF Ennis Inc.

Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialties, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360 Custom LabelsSM, ColorWorx, Enfusion, among others.

Share on Social Networks: